1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Genome Editing Market– By Technology

1.3.2        North America Genome Editing Market– By Application

1.3.3        North America Genome Editing Market– By End User

1.3.4        North America Genome Editing Market– By Country

2.           North America Genome Editing Market– Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Genome Editing Market– Market Landscape

4.1         Overview

4.2         PEST Analysis

4.3         Expert Opinion

5.           North America Genome Editing Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Surge in Prevalence of Cancer and Other Genetic Disorders

5.1.2        Ongoing Technological Advancements in Gene-Editing Tools

5.2         Market Restraints

5.2.1        Higher Cost of Genomic Equipment

5.3         Future Trends

5.3.1        Raising Technological Innovations

5.4         Impact Analysis

6.           North America Genome Editing Market Analysis

6.1         North America Genome Editing Market Revenue Forecast and Analysis

7.           North America Genome Editing Market Revenue and Forecasts to 2028– by Technology

7.1         Overview

7.2         North America Genome Editing Market, By Technology, 2021 & 2028 (%)

7.3         Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)

7.3.1        Overview

7.3.2        CRISPR: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

7.4         TALEN

7.4.1        Overview

7.4.2        TALEN: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

7.5         Antisense

7.5.1        Overview

7.5.2        Antisense: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

7.6         Others

7.6.1        Overview

7.6.2        Others: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

8.           North America Genome Editing Market Revenue and Forecasts to 2028 – Application

8.1         Overview

8.2         North America Genome Editing Market Share, By Application - 2021 & 2028 (%)

8.3         Cell Line Engineering

8.3.1        Overview

8.3.2        Cell Line Engineering: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

8.4         Genetic Engineering

8.4.1        Overview

8.4.2        Genetic Engineering: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

8.5         Diagnostic Applications

8.5.1        Overview

8.5.2        Diagnostic Applications: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

8.6         Drug Discovery

8.6.1        Overview

8.6.2        Drug Discovery: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

8.7         Others

8.7.1        Overview

8.7.2        Others: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

9.           North America Genome Editing Market Revenue and Forecasts to 2028 – End User

9.1         Overview

9.2         North America Genome Editing Market Share by End User - 2021 & 2028 (%)

9.3         Pharmaceutical and Biotechnology Companies

9.3.1        Overview

9.3.2        Pharmaceutical and Biotechnology Companies: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

9.4         Clinical Research Organizations (CRO’s)

9.4.1        Overview

9.4.2        Clinical Research Organizations: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

9.5         Academic and Research Institutes

9.5.1        Overview

9.5.2        Academic and Research Institutes: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

10.        North America Genome Editing Market Revenue and Forecasts to 2028 – Country Analysis

10.1      Overview:

10.1.1     North America: Genome Editing Market, by Country, 2021 & 2028 (%)

10.1.1.1       US: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1       Overview

10.1.1.1.2       US: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.3       US: Genome Editing Market, by Technology, 2019–2028 (US$ Million)

10.1.1.1.4       US: Genome Editing Market, by Applications, 2019–2028 (US$ Million)

10.1.1.1.5       US: Genome Editing Market, End User, 2019–2028 (US$ Million)

10.1.1.2       Canada: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1       Overview

10.1.1.2.2       Canada: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.3       Canada: Genome Editing Market, by Technology, 2019–2028 (US$ Million)

10.1.1.2.4       Canada: Genome Editing Market, by Applications, 2019–2028 (US$ Million)

10.1.1.2.5       Canada: Genome Editing Market, End User, 2019–2028 (US$ Million)

10.1.1.3       Mexico: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1       Overview

10.1.1.3.2       Mexico: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.3       Mexico: Genome Editing Market, by Technology, 2019–2028 (US$ Million)

10.1.1.3.4       Mexico: Genome Editing Market, by Applications, 2019–2028 (US$ Million)

10.1.1.3.5       Mexico: Genome Editing Market, End User, 2019–2028 (US$ Million)

11.        Impact Of COVID-19 Pandemic on North America Genome Editing Market

11.1      North America: Impact Assessment of COVID-19 Pandemic

12.        North America Genome Editing Market– Industry Landscape

12.1      Overview

12.2      Organic Developments

12.2.1     Overview

12.3      Inorganic Developments

12.3.1     Overview

13.        Company Profiles

13.1      THERMO FISHER SCIENTIFIC INC.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      MERCK KGaA

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Lonza

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Horizon Discovery Group plc.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Integrated DNA Technologies

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      GenScript

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      New England Biolabs

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Eurofins Scientific

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      CRISPR Therapeutics

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   Editas Medicine

13.10.1  Key Facts

13.10.2  Business Description

13.10.3  Products and Services

13.10.4  Financial Overview

13.10.5  SWOT Analysis

13.10.6  Key Developments

14.        Appendix

14.1      Glossary of Terms

LIST OF TABLES

Table 1.             US Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 2.             US Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)

Table 3.             US Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 4.             Canada: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 5.             Canada Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)

Table 6.             Canada Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 7.             Mexico: Genome Editing Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 8.             Mexico Genome Editing Market, by Applications– Revenue and Forecast to 2028 (US$ Million)

Table 9.             Mexico Genome Editing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 10.          Organic Developments Done by Companies

Table 11.          Inorganic Developments Done by Companies

Table 12.          Glossary of Terms, North America Genome Editing Market

LIST OF FIGURES

Figure 1.           North America Genome Editing Market Segmentation

Figure 2.           North America Genome Editing Market Segmentation, By Country

Figure 3.           North America Genome Editing Market Overview

Figure 4.           CRISPR Held Largest Share of Technology Segment in North America Genome Editing Market

Figure 5.           The US to Show Remarkable Growth During Forecast Period

Figure 6.           North America Genome Editing Market, Industry Landscape

Figure 7.           North America: PEST Analysis

Figure 8.           Expert Opinion

Figure 9.           North America Genome Editing Market Impact Analysis of Drivers and Restraints

Figure 10.        North America Genome Editing Market– Revenue Forecast and Analysis – 2019-2028

Figure 11.        North America Genome Editing Market, by Technology, 2021 & 2028 (%)

Figure 12.        CRISPR: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

Figure 13.        TALEN: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Antisense: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Others: Genome Editing Market Revenue and Forecast to 2028 (US$ Million)

Figure 16.        North America Genome Editing Market Share, by Application - 2021 & 2028 (%)

Figure 17.        Cell Line Engineering: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18.        Genetic Engineering: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19.        Diagnostic Applications: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 20.        Drug Discovery: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21.        Others: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22.        North America Genome Editing Market Share by End User - 2021 & 2028 (%)

Figure 23.        Pharmaceutical and Biotechnology Companies: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 24.        Clinical Research Organizations: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25.        Academic and Research Institutes: Genome Editing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 26.        North America: Genome Editing Market, by Key Country – Revenue (2021) (US$ Million)

Figure 27.        North America: Genome Editing Market, by Country, 2021 & 2028 (%)

Figure 28.        US: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Canada: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Mexico: Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31.        Impact of COVID-19 Pandemic in North American Country Markets